1 Min Read
Aug 22 (Reuters) - Puma Biotechnology Inc :
* Marketing authorization application for neratinib has been validated by European Medicines Agency Source text (bit.ly/2bxvgWa) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.